|By PR Newswire||
|August 4, 2014 02:46 PM EDT||
MARLBOROUGH, Mass., Aug. 4, 2014 /PRNewswire/ -- Lemelson Capital Management, a private investment management firm, today announced that it has further increased its short position in Ligand Pharmaceuticals (NASDAQ: LGND) and updated with new information its June 16 and July 3, 2014 research reports on the stock.
- Lemelson Capital's original June 16, 2014 report can be found here.
- Lemelson Capital's appended 12-paged update, published on July 3, 2014, can be found here.
"Ligand's 76 percent plunge in EPS, reported in the company's Q2 earnings release this morning, is alarming, while the negative impact of new oral regimens on interferon use and, parenthetically, Promacta sales have not yet hit the P & L of Ligand or its partner Amgen," Lemelson Capital Management's Chief Investment Officer Emmanuel Lemelson said in releasing today's updated Ligand Pharmaceuticals report. "Key revenue programs such as collaborative research and development are also continuing their multi-year slide, while stock-based compensation has reached new highs, far in excess of the company's insipid earnings," he said.
Today's updated research report on Ligand Pharmaceuticals includes new material information that has been added to the firm's original June 16, 2014 research report. Today's report can be found here.
Disclosure: Lemelson Capital is currently short shares of LGND for its clients.
About Lemelson Capital Management:
Lemelson Capital Management, LLC is a private investment management firm focused on deep value and special situation investments. The firm's flagship fund, The Amvona Fund, has been named repeatedly one of the world's top performing hedge funds. For more information, see: http://www.lemelsoncapital.com
Chief Investment Officer
Lemelson Capital Management, LLC
SOURCE Lemelson Capital Management, LLC
Internet of @ThingsExpo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devices - comp...
Aug. 26, 2016 10:15 AM EDT Reads: 3,561
Aug. 26, 2016 09:45 AM EDT Reads: 1,809
Aug. 26, 2016 09:45 AM EDT Reads: 119
Aug. 26, 2016 09:00 AM EDT Reads: 2,211
Aug. 26, 2016 07:00 AM EDT Reads: 3,904
Aug. 26, 2016 05:00 AM EDT Reads: 3,023
Aug. 26, 2016 03:15 AM EDT Reads: 1,406
Aug. 26, 2016 02:15 AM EDT Reads: 1,947
Aug. 26, 2016 01:30 AM EDT Reads: 1,665
Aug. 26, 2016 01:15 AM EDT Reads: 2,017
Aug. 26, 2016 01:00 AM EDT Reads: 1,956
Aug. 26, 2016 12:45 AM EDT Reads: 2,264
Aug. 26, 2016 12:30 AM EDT Reads: 2,903
Aug. 25, 2016 11:45 PM EDT Reads: 2,287
Aug. 25, 2016 10:45 PM EDT Reads: 1,878